P0378 : Time to progression of AFP is an independent prognostic factor of survival in hepatocellular carcinoma treated with sorafenib. Internal validation
Varela, M., Blanco-García, L., Castaño-Fernández, O., González-Diéguez, M.L., Cadahía-Rodrigo, V., Álvarez-Navascués, C., Pérez-Álvarez, R., Mesa, A., Hernández-Luyando, L., Rodríguez, M.Volume:
62
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(15)30591-2
Date:
April, 2015
File:
PDF, 39 KB
english, 2015